Key facts
- It has raised $100K; the latest was Seed Round ($100K) in Sep 2025.
- Notable investors include Neuroceuticals.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MovoMind
- ·The full record, as it builds
Funding rounds
No funding rounds for MovoMind are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MovoMind
Provider of healthcare services intended to assist people with Parkinson's disease. The company offers digital technology, a PD diary, and tracking of patient symptoms and medication dosage, and provides online community services to share awareness about Parkinson's disease, enabling caregivers and healthcare professionals to enhance their patient care.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2024
- Employees
- 6
- Website
- movomind.com/
- Ownership
- Privately Held (backing)
MovoMind doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MovoMind shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MovoMind in its N-PORT filings yet. We sweep new filings monthly.